Gift Adu Bukola, Otorkpa Michael Joseph, Olayode Oluwatobi O, Joseph Ebubechukwu David, Abdulhakeem Ademola, Nchonganyi Efuetlateh John Paul, Anele Feziechi Chikelundu, Habib Akolade Akeem, Ghislain Junior Fodop Samuel, Akintoye Oluwanifemi O, Benjamin Omoregbee
Cardiothoracic Surgery, Surgery Interest Group of Africa, Lagos 100001, Nigeria.
Ecancermedicalscience. 2025 Jul 22;19:1951. doi: 10.3332/ecancer.2025.1951. eCollection 2025.
Lung cancer is the leading cause of cancer death worldwide, with an estimated 1.8 million deaths in 2020. Despite the advancement of new treatment strategies that have emerged over time, surgery remains a very important aspect of cancer treatment. This study aims to highlight the long-term outcomes of surgery as well as the healthcare gaps in the diagnosis and treatment of Lung cancer in Africa by providing a comprehensive systematic review and meta-analysis.
This systematic review was conducted using database searches from PubMed and Google Scholar to identify published data reporting on the surgical outcomes of lung cancer in Africa from inception till August 2024. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines to conduct this study. The primary outcomes of interest were overall mortality, 1- and 5-year survival rates, metastasis, morbidity and recurrence. Data were pooled together and analysed using a random-effect model for meta-analysis with R software. Out of a total of 381 articles identified, only eight papers met our inclusion criteria following deduplication and screening. The five countries with published research on our topic include Egypt, Kenya, Tunisia, Nigeria and Morocco, with a total sample size of 2150 patients.
The meta-analysis of the reported outcomes produced an overall mortality rate of 27%, a 1-year survival rate of 56%, a 5-year survival rate of 13%, metastases of 76.9%, morbidity of 7.7% and recurrence of 11.4%.
The burden of lung cancer is relatively high across the African continent, with surgical treatment significantly underutilised due to several factors, including an inadequate number of skilled healthcare workers, limited cardiothoracic surgical services and the advanced stage at which most patients present. Nevertheless, there is room for improvement by addressing these gaps through targeted investments in cardiothoracic surgical training, research and infrastructure, alongside increased awareness of lung cancer and the benefits of screening services across Africa. These measures, combined with joint international and governmental funding efforts, could significantly improve survival outcomes.
肺癌是全球癌症死亡的主要原因,2020年估计有180万人死亡。尽管随着时间的推移出现了新的治疗策略,但手术仍然是癌症治疗的一个非常重要的方面。本研究旨在通过提供全面的系统评价和荟萃分析,突出手术的长期结果以及非洲肺癌诊断和治疗中的医疗差距。
本系统评价通过在PubMed和谷歌学术上进行数据库搜索,以识别从开始到2024年8月期间报告非洲肺癌手术结果的已发表数据。我们遵循系统评价和荟萃分析的首选报告项目指南进行本研究。感兴趣的主要结果是总死亡率、1年和5年生存率、转移、发病率和复发率。数据汇总在一起,并使用R软件的随机效应模型进行荟萃分析。在总共识别出的381篇文章中,经过去重和筛选后,只有8篇论文符合我们的纳入标准。对我们的主题进行了已发表研究的五个国家包括埃及、肯尼亚、突尼斯、尼日利亚和摩洛哥,总样本量为2150名患者。
对报告结果的荟萃分析得出总死亡率为27%,1年生存率为56%,5年生存率为13%,转移率为76.9%,发病率为7.7%,复发率为11.4%。
非洲大陆肺癌负担相对较高,由于多种因素,包括熟练医护人员数量不足、心胸外科服务有限以及大多数患者就诊时处于晚期,手术治疗的利用率明显不足。然而,通过有针对性地投资于心胸外科培训、研究和基础设施,同时提高非洲对肺癌和筛查服务益处的认识,这些差距是有改善空间的。这些措施,再加上国际和政府的联合资助努力,可以显著改善生存结果。